68
Participants
Start Date
August 31, 2016
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Harvoni
Treatment of Hepatitis C with sofosbuvir based HCC therapy
Mt. Sinai Medical Center, New York
Columbia University, New York
University of Pennsylvania, Philadelphia
Georgetown University, Washington D.C.
National Institutes of Health Clinical Center, Bethesda
University of Maryland, Baltimore
Johns Hopkins Medical Center, Baltimore
University of California, San Francisco, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Icahn School of Medicine at Mount Sinai
OTHER
Columbia University
OTHER
University of Pennsylvania
OTHER
University of Maryland, College Park
OTHER
Georgetown University
OTHER
Johns Hopkins University
OTHER
National Institutes of Health Clinical Center (CC)
NIH
University of California, San Francisco
OTHER